Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
30 Results Found
AHA podcast: Pharmacy Deserts, Rising Demand and the Future of Pharmacy Access
John Pastor, president of Fairview Pharmacy Services and chief operating officer of Fairview Pharmacy Solutions, shares how M Health Fairview’s expansive pharmacy network, centralized services hub and integrated technology are reshaping medication access in Minnesota and beyond.
Pharmacy Deserts, Rising Demand, and the Future of Pharmacy Access
As pharmacy closures accelerate nationwide, M Health Fairview is proving what’s possible when a health system steps up.
Atlantic Health targets polypharmacy
Morristown, N.J.-based Atlantic Health System will soon deploy an AI-based technology that flags polypharmacy issues.
3 Ways Pharma Could Jolt Health Care in 2023
The market for biosimilar drugs to treat cancer, inflammatory diseases, diabetes and more will continue to expand, ideally resulting in lower prices as more pharmaceutical patents expire and competitors enter the market.
Administration reaches deal with AstraZeneca on lowering drug costs
The White House Oct. 10 announced it reached an agreement with AstraZeneca to align drug prices with the lowest paid by other developed nations, also known as the most-favored-nation price.
Administration announces agreement with Pfizer to lower drug costs
President Trump today announced the first agreement with a major pharmaceutical company, Pfizer, to bring American drug prices in line with the lowest paid by other developed nations — wh
FDA discloses warning letters for dozens of drug companies
The Food and Drug Administration recently disclosed dozens of warning letters sent to drug companies that accuse them of using misleading or deceptive advertising.
Trump directs HHS, FDA to require full safety warnings in drug ads
President Trump Sept. 10 signed a memorandum directing the Department of Health and Human Services and Food and Drug Administration to require drug companies to include full safety warnings on their consumer advertisements.
FDA announces new program to boost domestic drug manufacturing
The Food and Drug Administration Aug. 7 announced a new program to help improve the domestic pharmaceutical supply chain by increasing regulatory predictability and facilitating the construction of drug manufacturing facilities in the U.S.
JAMA study finds changing default prescription length can possibly reduce pharmacy trips, lower mortality
A JAMA Internal Medicine study published April 7 examined the effects of changing the default prescription lengths for statins, which are cholesterol-lowering medications, from 2022 to 2024. The study noted that higher rates of possession of such medications are often associated with a lower risk of death.